Navigation Links
Thrombosis Experts Present Update on Important New Developments in Anticoagulation Management
Date:10/29/2010

the prevention and treatment of patients at risk for thrombotic and vascular disorders including atrial fibrillation, acute coronary syndromes, diabetes, cancer and transplantation associated venous occlusive disorder.  In addition, the panel considered recent worldwide regulatory developments that are changing the landscape of anticoagulation therapy which includes the introduction of newer oral anticoagulants and generic versions of branded drugs.  The symposium was very well attended and a number of the hematology professionals who attended expressed their appreciation of this timely and informative session.

Pharmaceutical Strategic Initiatives LLC (PSI) is the premier provider of strategic clinical and regulatory consulting, priority comparative effectiveness and outcomes research, scientific content creation, opinion leader development and management to Academic Institutions, Pharmaceutical, Medical Device and Biotechnology companies. For 26 years, PSI has supported Educational Programs and Workshops, Medical Affairs, Regulatory Affairs, and Medical Marketing teams by developing successful business strategies and providing the implementation skills required to produce clear, measurable outcomes.  Charles A. Carter, Pharm.D., MBA is president of Pharmaceutical Strategic Initiatives, LLC.  PSI's offices are in Research Triangle Park, North Carolina.


'/>"/>
SOURCE Pharmaceutical Strategic Initiatives LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
2. VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009
3. The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment
4. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
5. Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
6. Nanobiotechnology experts join forces to improve TB testing
7. Bait and Switch TV's Free Live Debates Invite TV Viewers to Debate with Experts in Real Time about Controversial Topics
8. Leading Cord Blood Experts Clarify Their Support of CORD:USE Family Cord Blood Bank
9. New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting
10. What's Next for Stevia? Experts from GLG Life Tech Corp Share Views on Stevia's Future at Complimentary Webinar on 17 Feb.
11. Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Mass. (PRWEB) , ... July 06, 2015 , ... ... Worcester Polytechnic Institute (WPI), offers new insights into how virulent fungi adapt through ... their spread, and how that battle leaves them temporarily weakened. These insights may ...
(Date:7/6/2015)... SANTA BARBARA, Calif. , July 6, 2015 /PRNewswire/ ... virus that is integrated into their chromosomes. These individuals ... to a new study published in one of the ... Laval Faculty of Medicine in Canada.  Photo ... known as human herpesvirus 6 (HHV-6) causes roseola (also ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... and cheaper molecular diagnostic tests are key drivers of the global molecular diagnostics ... personalized medicine and the introduction of new companion diagnostic tests will increase demand ...
(Date:7/6/2015)...  Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), a company focused on ... Chief Executive Officer, and Scott Durbin , Viveve,s Chief ... 2015. , , , DATE:    , , ... TIME:     , , , 12:15 PM EDT , ... http://tinyurl.com/viveve   ,    ...
Breaking Biology Technology:Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 4Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 2Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 3Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3
... April 30 Today John C. Lechleiter,Ph.D., president ... LLY ), provided,insight into the future of ... players, significant investments in the sector are rewarded. ... a gathering of,policymakers, business leaders and academics, under ...
... 30 Intense global competition,and today,s networked economy ... Alliances as the strategy of the next century. ... it to be sustainable and,mutually beneficial., How ... study on Forging,Partnerships That Work is a roadmap ...
... Inc. (Nasdaq: PBIO ) today announced that the ... 2008 financial results and to,provide a business update. Anyone ... through a live web-cast. The,teleconference and web-cast information is ... Time: 9:00 a.m. Eastern Time (ET), To attend ...
Cached Biology Technology:Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth 2Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth 3Biopharmaceutical Alliances: Forging Partnerships That Work 2Pressure BioSciences, Inc. to Discuss First Quarter 2008 Financial Results and Provide Business Update 2
(Date:6/16/2015)... , June 16, 2015 Fingerprint Cards ... communicated that it will amount to at least 340 MSEK ... to the rapid increase in market growth and orders received ... communicated guidance that revenue for 2015 will exceed 1,500 MSEK ... to approximately 2,200 MSEK. Due to receipt of ...
(Date:6/15/2015)... 15, 2015 A new report [ ... the majority of US consumers using mobile banking applications want ... as fingerprint and voiceprint, instead of having to prove who ... Telstra,s " Mobile Identity   -   The Fusion of ... smartphones now the primary channel used by Gen X and ...
(Date:6/12/2015)... June 12, 2015  Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring, announced ... to electronically capture, analyze and identify participants of ... methods. This system can: ... enrollment and subsequent sign-on process is actually the ...
Breaking Biology News(10 mins):Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... skin. Cancer is not a static disease but during ... defences adapting to new environmental circumstances, protecting against chemotherapy ... Until now little was known about the mechanisms ... is a particularly intriguing way in which a tumour ...
... of carbon in the world,s oceans, which cover 70 ... climate cycles, with many questions remaining unanswered. Between 200 ... "twilight zone" where insufficient sunlight penetrates for microorganisms to ... resident at these depths capture carbon dioxide that they ...
... of spring-run Chinook salmon in California by the end ... at UC Davis, the Stockholm Environment Institute and the ... for managing water resources to protect the salmon runs, ... Thompson, director of the Center for Aquatic Biology and ...
Cached Biology News:Why cancer cells change their appearance? 2Up from the depths: How bacteria capture carbon in the 'twilight zone' 2Warming streams could be the end for salmon 2
Clarin Mounting Medium (Permanent environmentally safe mounting medium for general histology & cytology use)...
... Rabbit polyclonal to JAK2 (phospho ... tested applications). Antigen: ... JAK2 around the phosphorylation site of ... Entrez Gene ID: ...
... Perm Buffer III is ... fixation of PBMCs (or ... staining for intracellular kinases ... simultaneously. Applications: Intracellular ...
Cytofix/Cytoperm Kit 250 Tests...
Biology Products: